U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07045155) titled 'Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis' on June 04.
Brief Summary: This study is a prospective, multicenter, parallel-controlled, open-label clinical trial, planned to be conducted across multiple research centers in various provinces and cities in China.
It will enroll 240 dialysis-dependent chronic kidney disease (DD-CKD) patients with anemia who have been receiving rHuEPO treatment for at least 4 weeks, with hemoglobin (Hb) levels of >=70 g/L and <110 g/L. After enrollment, participants will be randomly assigned in a 1:1:1 ratio to the experimental group, control group, and exploratory group....